Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John D Scandling

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
JAMA Network Open|March 10, 2022
Trends in Cost Attributable to Kidney Transplantation Evaluation and Waiting List Management in the United States, 2012-2017Xingxing S Cheng, Jialin Han, Jennifer L Braggs-Gresham, et al.
Transplantation|May 23, 2002
Mixed chimerism and immunosuppressive drug withdrawal after HLA-mismatched kidney and hematopoietic progenitor transplantationMaria T Millan, Judith A Shizuru, Petra Hoffmann, et al.
Frontiers in Immunology|February 17, 2022
Successful Induction of Specific Immunological Tolerance by Combined Kidney and Hematopoietic Stem Cell Transplantation in HLA-Identical SiblingsThomas Fehr, Kerstin Hübel, Olivier de Rougemont, et al.
Medical Care|June 18, 2024
The Medical Costs of Determining Eligibility and Waiting for a Kidney TransplantationKunyao Xu, Avi Dor, Suman Mohanty, et al.
Science Translational Medicine|January 31, 2020
Mixed chimerism and acceptance of kidney transplants after immunosuppressive drug withdrawalStephan Busque, John D Scandling, Robert Lowsky, et al.
Blood Advances|August 25, 2021
Development of immunosuppressive myeloid cells to induce tolerance in solid organ and hematopoietic cell transplant recipientsKent P Jensen, David A Hongo, XuHuai Ji, et al.
Transplantation|July 25, 2017
Developing Consensus-Based Priority Outcome Domains for Trials in Kidney Transplantation: A Multinational Delphi Survey With Patients, Caregivers, and Health ProfessionalsBénédicte Sautenet, Allison Tong, Karine E Manera, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
JAMA Network Open|March 10, 2022
Trends in Cost Attributable to Kidney Transplantation Evaluation and Waiting List Management in the United States, 2012-2017Xingxing S Cheng, Jialin Han, Jennifer L Braggs-Gresham, et al.
Transplantation|May 23, 2002
Mixed chimerism and immunosuppressive drug withdrawal after HLA-mismatched kidney and hematopoietic progenitor transplantationMaria T Millan, Judith A Shizuru, Petra Hoffmann, et al.
Frontiers in Immunology|February 17, 2022
Successful Induction of Specific Immunological Tolerance by Combined Kidney and Hematopoietic Stem Cell Transplantation in HLA-Identical SiblingsThomas Fehr, Kerstin Hübel, Olivier de Rougemont, et al.
Medical Care|June 18, 2024
The Medical Costs of Determining Eligibility and Waiting for a Kidney TransplantationKunyao Xu, Avi Dor, Suman Mohanty, et al.
Science Translational Medicine|January 31, 2020
Mixed chimerism and acceptance of kidney transplants after immunosuppressive drug withdrawalStephan Busque, John D Scandling, Robert Lowsky, et al.
Blood Advances|August 25, 2021
Development of immunosuppressive myeloid cells to induce tolerance in solid organ and hematopoietic cell transplant recipientsKent P Jensen, David A Hongo, XuHuai Ji, et al.
Transplantation|July 25, 2017
Developing Consensus-Based Priority Outcome Domains for Trials in Kidney Transplantation: A Multinational Delphi Survey With Patients, Caregivers, and Health ProfessionalsBénédicte Sautenet, Allison Tong, Karine E Manera, et al.
Pageof 3